Kalvista Pharmaceuticals, Inc. · NASDAQ:KALV

Palleiko Benjamin L sold 9,550 Kalvista Pharmaceuticals, Inc. shares (Form 4)

Traded Apr 16 to Apr 17, 2026 · Filed Apr 20, 2026

From Apr 16 to Apr 17, 2026, Palleiko Benjamin L (Director, CHIEF EXECUTIVE OFFICER) sold 9,550 Kalvista Pharmaceuticals, Inc. shares at US$20.22 for US$193K, leaving 462,577 shares. Filed Apr 20, 2026 (Form 4).

Sold
9,550 shares
Price
US$20.22
Value
US$193K
Holding after
462,577 shares
Trading plan
No
Role
Director, CHIEF EXECUTIVE OFFICER

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Apr 16, 2026Common StockOption exercise20,312472,127Direct
Apr 17, 2026Common StockSale9,550US$20.22462,577Direct

Source

View original at SEC

Related